Watch the video presentation  

NIOX VERO® is a point-of-care device for assessing airway inflammation in patients with respiratory problems such as asthma. NIOX VERO is a further development of NIOX MINO®, the most widely used device for measuring airway inflammation in clinical practice and clinical studies all over the world.

Expected characteristics for a point-of-care device

  • Easy to use
  • Quick results
  • Reliable and accurate results
  • Trouble free maintenance

What NIOX VERO® gives you

Easy to use and quick results

  • Designed with patients and health care professionals in mind to ensure best performance
  • Can be used both for children and adults (provided patient cooperation)
  • Short start-up time
  • Quick analysis time, within a minute

Facilitates clinical management decisions at the point of care

Reliable and accurate results

  • Internal check of electronics every time at start-up.
  • Measurement result obtained only when the patient completes procedure correctly
  • Good repeatability allows for one measurement only
  • Follows ATS/ERS equipment recommendations
  • CE marked

Quality assured measurement results you can rely upon

Trouble free maintenance

  • Service and maintenance free device
  • 5 years shelf-life and 15 000 measurements
  • No calibration required

A product you can rely upon

NIOX VERO ® specifications

Exhaled NO – Performance Data  
Measurement range: FeNO 5 to 300 ppb
Exhalation time
10 seconds
Measurement time
1 min
± 5 ppb or max 10%
Precision <3 ppb of measured value <30 ppb
<10% of measured value ≥30 ppb
Instrument memory capacity 15000 measurements
Dimensions (height x width x depth) 145 mm x 185 mm x 41 mm
Weight (including Sensor)
1 kg
 Shelf-life (device) Minimum 5 years at time of delivery, or 15000 measurements.


NIOX VERO® is CE-marked according to In Vitro Diagnostic Device Directive 98/79/EC and approved for clinical use in EEC Countries.

NIOX VERO® is 510(k) cleared by FDA.


CPT 95012